Dr. Camila De Oliveira Melo – Nanotecnologia – Young Scientist Award

Posted on by sciencefather

Dr. Camila De Oliveira Melo - Nanotecnologia - Young Scientist Award

Universidade Estadual da Paraíba - Brazil

Author Profile

SCOPUS

ORCID

🎓 Early academic pursuits

Camila De Oliveira melo began her journey into the world of pharmaceuticals with a bachelor’s degree in pharmacy from universidade estadual da paraíba (uepb) in 2015. her early academic interests focused on innovative drug delivery systems, specifically the pre-formulation study of polymeric nanoparticles to carry l-asparaginase, a promising approach for cancer treatment. her drive to explore advanced biotechnological solutions led her to pursue a master’s degree in pharmaceutical sciences (2018), where she worked on pla nanoparticles containing spiro-acridinic derivatives with anticancer activity. her strong foundation in biotechnology and pharmacy culminated in her doctoral degree from rede nordeste de biotecnologia (renorbio) at universidade federal do rio grande do norte (ufrn), where she focused on drug delivery systems aimed at cancer therapy using spiro-acridinic derivatives.

🔬 Professional endeavors

Camila’s professional experience is deeply rooted in biotechnology and pharmaceutical sciences. she has worked extensively in developing polymeric nanoparticles, contributing to innovative cancer treatments. her research during her doctorate involved the development and biological evaluation of spiro-acridinic-derived drug delivery systems, demonstrating her commitment to advancing cancer therapies. her expertise also extends to the creation of nanoemulsions containing essential oils, which offer potential in various pharmaceutical applications. camila has shown consistent dedication to improving the efficacy and solubility of hydrophobic drugs through inclusion complexes, broadening her contribution to pharmaceutical sciences.

🧬 Contributions and research focus

Camila's primary research focus lies in the development of cutting-edge drug delivery systems. her work has emphasized the creation of polymeric nanoparticles, specifically pla-based systems, aimed at improving the accumulation of therapeutic agents in tumor tissues via the enhanced permeability and retention (epr) effect. Nanotecnologia her research has contributed significantly to the advancement of cancer treatment, with a focus on increasing the bioavailability and effectiveness of hydrophobic drugs. additionally, camila’s exploration of nanoemulsions and inclusion complexes has opened doors for future applications in drug solubility and targeted delivery.

🏆 Accolades and recognition

in 2022, camila was recognized as one of the six brazilian researchers selected for the prestigious course "nanobiotecnologia aplicada ao combate da covid19," funded by the ministry of science, technology, and innovations (mctic). this recognition highlights her role as a leading figure in nanotechnology applications in brazil, Nanotecnologia particularly her expertise in employing nanoparticles for critical health challenges like cancer and covid-19. her work has been supported by notable funding bodies like the foundation for research support of the state of paraíba (fapesq), showcasing the trust in her research contributions.

🌍 Impact and influence

Camila’s contributions to cancer research, particularly in the area of nanoparticle-based drug delivery systems, have had a significant impact on the field of pharmaceutical biotechnology. her research has the potential to revolutionize cancer treatment by offering more effective drug delivery methods, enhancing drug Nanotecnologia solubility, and reducing side effects. her work on nanoemulsions and inclusion complexes also presents a wide range of pharmaceutical applications, influencing future research in drug development. camila's selection for the nanobiotechnology course reflects her growing influence in both national and international scientific communities.

🔮 Legacy and future contributions

Camila de Oliveira melo’s legacy lies in her groundbreaking research on nanoparticle-based drug delivery systems for cancer therapy. her work is a testament to her commitment to innovation and improving patient outcomes. moving forward, she is likely to continue making strides in the development of advanced drug delivery technologies, with the potential to influence future research in oncology, nanotechnology, and biopharmaceuticals. her expertise in enhancing drug solubility and efficacy positions her as a key player in the future of pharmaceutical biotechnology.

Notable Publications 

  • Title: Enhancing the Antischistosomal Activity of Carvacryl Acetate Using Nanoemulsion
    Authors: De Souza, R.L., Mengarda, A.C., Roquini, D.B., Moraes, J.D., Oliveira, E.E.
    Journal: Nanomedicine, 2023, 18(4), pp. 331–342
  • Title: Nanotechnology as a Tool to Improve the Biological Activity of Carvacrol: A Review
    Authors: Souza, R.L.D., Dantas, A.G.B., Melo, C.D.O., Felício, I.M., Oliveira, E.E.
    Journal: Journal of Drug Delivery Science and Technology, 2022, 76, 103834
  • Title: Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis
    Authors: Xavier, E.S., de Souza, R.L., Rodrigues, V.C., Oliveira, E.E., de Moraes, J.
    Journal: Frontiers in Pharmacology, 2022, 13, 917363
  • Title: The Compound (E)-2-Cyano-N,3-diphenylacrylamide (JMPR-01): A Potential Drug for Treatment of Inflammatory Diseases
    Authors: Da Silva, P.R., Do Espírito Santo, R.F., Melo, C.O., de Moura, R.O., Dos Santos, V.L.
    Journal: Pharmaceutics, 2022, 14(1), 188
  • Title: Xylan Microparticles for Controlled Release of Mesalamine: Production and Physicochemical Characterization
    Authors: Urtiga, S.C.D.C., Alves, V.M.O., Melo, C.D.O., Oliveira, E.E., Egito, E.S.T.D.
    Journal: Carbohydrate Polymers, 2020, 250, 116929

Dr. Vikas Shukla – Nanomedicine and Immunology – Best Researcher Award

Posted on by sciencefather

Dr. Vikas Shukla - Nanomedicine and Immunology - Best Researcher Award

AIIMS, New Delhi - India 

Author Profile

GOOGLE SCHOLAR 

Early academic pursuits 📚

Vikas Shukla's academic journey began with a deep-rooted passion for nanobiotechnology and immunology. He dedicated himself to gaining a solid foundation in the life sciences, eventually leading him to pursue advanced studies in these cutting-edge fields. His education, characterized by rigorous training, provided the tools necessary for his future contributions to scientific research. Over the years, vikas built an impressive knowledge base in bacterial culture, cell culture, and immunoassays, which would serve as the backbone of his research career.

Professional endeavors 🏢

currently serving as a research scientist-II at the all india institute of medical sciences (aiims) in new delhi, india, vikas brings over 8 years of extensive experience to the forefront. His role at aiims, within the department of plastic, reconstructive & burns surgery, involves not only laboratory-based research but also project management. This balance between hands-on science and overseeing project timelines ensures that he contributes effectively to the scientific and clinical goals of his department.

Contributions and research focus 🔬

Vikas's research primarily revolves around nanobiotechnology and immunology, with a keen focus on innovative solutions in medical science. He has demonstrated exceptional expertise in bacterial culture, cell culture, immunoassays, and small animal handling. His work seeks to bridge the gap between complex scientific Nanomedicine and Immunology theories and their real-world applications, particularly in healthcare. Vikas’s research outputs have helped advance understanding in both fundamental immunological responses and the application of nanotechnology in therapeutic treatments.

Accolades and recognition 🏅

throughout his career, vikas has received commendations for his meticulous work and contributions to the field. His ability to keep projects both on time and on Nanomedicine and Immunology budget while maintaining high scientific standards has not gone unnoticed. He is widely recognized among his peers and colleagues for his diligence, precision, and ability to translate complex scientific concepts into more accessible knowledge. His exceptional communication skills have further bolstered his reputation as a skilled researcher and project manager.

Impact and influence 🌍

Vikas’s research holds significant implications for the fields of immunology and nanobiotechnology, particularly within clinical settings. His work on developing innovative medical treatments and enhancing immunological responses has the potential to save lives and improve patient outcomes. His influence extends beyond the laboratory, as his project management skills ensure that critical research is completed efficiently, benefiting both the scientific community and society as a whole.

Legacy and future contributions 🔮

looking ahead, Vikas Shukla’s legacy will likely be defined by his contributions to advancing the use of nanotechnology in medicine. His ongoing work at aiims and within the broader scientific community will continue to impact the development of new therapeutic approaches and enhance our understanding of immune Nanomedicine and Immunology responses. His commitment to pushing the boundaries of science while managing complex projects ensures that his influence will be felt for years to come.

Notable Publications 

Smart Drug-Delivery Systems in the Treatment of Rheumatoid Arthritis: Current, Future Perspectives  2021

Dynamic light scattering (DLS) particle size analysis for biomedical nanotechnology  2023

Downmodulation of lysophosphatidic acid by Berberine loaded folate-conjugated glycol chitosan nanoparticles  2022

Therapeutic use of mesenchymal stem cells against SARS-Cov-2: present and future prospects  2022

Phytomedicine Meets Nanotechnology: A Cellular Approach to Rheumatoid Arthritis Treatment 2024

Dr. Ananda Kumar Chettupalli – Nanotechnology – Best Researcher Award

Posted on by sciencefather

Dr. Ananda Kumar Chettupalli - Nanotechnology - Best Researcher Award

Galogotias University - India

Professional Profile

ORCID

GOOGLE SCHOLAR

Early Academic Pursuits

Dr. Ananda Kumar Chettupalli embarked on his academic journey with a strong focus on pharmaceutical sciences, culminating in a Ph.D. under the guidance of Dr. Kunduri Rajeswar Dutt. His early academic pursuits laid the foundation for his extensive career in academics and research, emphasizing advanced nanotechnology formulations, statistical modeling for drug design, and core pharmacokinetic studies.

Professional Endeavors

Dr. Chettupalli has accumulated over 12.6 years of professional experience in academia and research: During his tenure, he has made significant contributions to the field, publishing 35 articles in reputed national and international journals. He has also secured several patents, including grants from Australia and Germany, demonstrating his innovative research contributions in novel drug delivery systems and pharmaceutical technology.

Contributions and Research Focus

Dr. Chettupalli's research interests are centered on developing novel and targeted drug delivery systems: He specializes in Ethosomes, Liposomes, Niosomes, Phytosomes, Spanlastics, Microspheres, Solid lipid nanocarriers, Nanostructured lipid carriers, and Polyherbal drug Nanotechnology formulations.His expertise extends to conducting Phytochemical studies, in-silico evaluations, and both in-vitro and in-vivo assays, enhancing the efficacy and safety profiles of pharmaceutical formulations.

Accolades and Recognition

His contributions have earned him recognition, including invitations as a resource person to international conferences like the ICNPU in Bulgaria Nanotechnology (2019). His patent grants and publications underscore his impact on advancing pharmaceutical sciences through innovative research.

Impact and Influence

Dr. Chettupalli's influence spans academia and industry, evident from his collaborations with governmental agencies for project funding and industry interactions. His research outputs and mentorship have contributed to the development of cutting-edge pharmaceutical technologies Nanotechnology and methodologies.

Legacy and Future Contributions

Dr. Chettupalli's commitment to learning and growth, coupled with his positive attitude and perseverance, positions him to make significant future contributions. His ongoing research in novel drug delivery systems and continued mentorship of doctoral and master's students will likely leave a lasting impact on the pharmaceutical sciences community, fostering innovation and academic excellence.

NOTABLE PUBLICATIONS

Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel  2021(51)

Nano phytomedicine based delivery system for CNS disease 2020(38)

Nanocrystals: Characterization overview, applications in drug delivery, and their toxicity concerns  2020(36)

Design, formulation, in-vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel 2021(31)

Pharmaceutical drug product development and process optimization: effective use of quality by design 2020(28)